ECJ DECISION HELPS TO ENSURE PATIENT ACCESS TO GENERIC MEDICINES
Submitted by sanjaypatel on Sun, 08/29/2010 - 13:40 The European Generic medicines Association has welcomed the Decision from the European Court of Justice, which has endorsed the European Commission's findings that Astra Zeneca abused its dominant position in the market for proton pump inhibitors. The Court confirmed there was clear evidence of anti-competitive activity, through misuse of the patent and regulatory systems, in order to delay the entry of generic Omeprazol, the active ingredient in the company's blockbuster drug, Losec.
